{"name":"Peregrine Pharmaceuticals","slug":"peregrine-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":53603000,"revenueGrowth":0,"grossMargin":0,"rdSpend":28297000,"netIncome":-140753000,"cash":336557000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOTlQzRkpQQlZDZXVlTFU3RzJWVV9HN3RhdWxyQ1gxdGJDaHFvZWpFQy1tOWRDbXhESDk2RkVWajdQZ2NhSTFncGlxTF9WTEVXMTdYZlhWdmd6NVI3b1FTbGdCZjNGTXBrVWp3S19GUF9DZlh0OFF3RXI0cU1XMFZhVXFzZjJZVkNpUU95bm9Jc0Y3Sm9yMkFoQ1dTTzNPb29PY0MwZ2VWaXJNR3d0WHgtY1BXV0FFWlMzZFRwdGl6VmR5U2xGMUNSLTRLdm9UQ2p6dVlvYU1BemYySTVLTE5va3ZFdmxvb0thRXNUNzlCVWJld0VuUDZn?oc=5","date":"2025-09-09","type":"pipeline","source":"PR Newswire","summary":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight - PR Newswire","headline":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQQUdvYlFoVko0cjFPOGgzd0hURkd4TmZySlhyZFpxVk9RejdzWlVWdW9MUVFBRm1VdnN6ak9pd0FWdUU0Y29iNHl3MTdxSTdvekRhVll2cXVaa1pFR3gwZXQyS1FQVUk5MWhENVJ3Wk9TNnZrd1NZNGM1cHU3bVJIOFE1S3M4MUp4dmExdDRLNFkxR1RkTnZub1p1Z1FDVjlmdUVOWFhjMENHZ0ppenc?oc=5","date":"2025-05-15","type":"deal","source":"PharmTech.com","summary":"Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator - PharmTech.com","headline":"Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPT2FoWW9MUnVDRVdUYW5haklta3RwdzJQaEF4cUtlM0dYR2FuZURwUzVaRERGa3FOaEFsVG9KYzVHQzVwcWNUdG4yQ2VBMllfRGh3T0djS0EzX09UMjBQWXhlU2Y4eWlBZUsyekp5eVl0cXJ1cExNSlFWOFA4U1N4aG5LUmFXYXRsdlhNdDR0c1VLaFNyMWZRcFplb1JwbE54QTVjc3JtRXVpUQ?oc=5","date":"2025-01-07","type":"deal","source":"Fierce Pharma","summary":"Klick Health swoops in to acquire life sci market access agency Peregrine - Fierce Pharma","headline":"Klick Health swoops in to acquire life sci market access agency Peregrine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPTTZVNjNkb3JpTk9SQWM3UFlRRUZjTjVNMlFnRWEwUU9DRHNXNHRtcVBpZ2NSLVlDWE1HUmtKMTFjcy1Ia3liRnk4VGJ2TWIzOWVEWVZYNEtFRlJySE5kOUlfT3E0X3NTSmxMQTA4eHZ4bnNHV3JWdHFNVVJDdWZVeV9n?oc=5","date":"2025-01-07","type":"deal","source":"Pharmaceutical Executive","summary":"Klick Health Acquires Peregrine Market Access - Pharmaceutical Executive","headline":"Klick Health Acquires Peregrine Market Access","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPUWZVdGZsdy14WVluZXpEQVUxZnEtcmJSMngyaGdtaGtoU3NucHQxX0h6OG1sVUgteV9DTTdla1QwcW1iVUxjTnpLdnJfUDQwTV9iTUJ1Z1dSMmEyUDNlekYwQ19mVUpGN1RDd0pFMjh5TW95OWM0WXNTc2FXVTlabmFxc01WckRLbWhEYmdIUWtHaDRx?oc=5","date":"2024-11-07","type":"deal","source":"BioProcess International","summary":"PE to buy CDMO Avid Bioservices for $1.1 billion - BioProcess International","headline":"PE to buy CDMO Avid Bioservices for $1.1 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOemV3NkNZeUFjcWprTElRMHdMaEVkT0JqSmJ5QUJjS2hnal9XQmhSV0NmejJpc3dSekdJUW01WFI3a29wUWpYUjhVdUxJY3p1bUNkSmtKMWdCb0RmLThJUjZOY3pXUmI5ZGdGUmtmTE1lTHRRNVd2cGNHZFo3S1QxTThCMU9PVUxxSkNjV2R2VnltcjZvcW41N21GVXZHUmVZRHRWaGdBZGJKRFM5?oc=5","date":"2024-11-07","type":"pipeline","source":"MedCity News","summary":"Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition - MedCity News","headline":"Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-06-25","type":"deal","source":"Business Wire","summary":"Monoclonal Antibody Collaboration and Licensing Deals Trends Report 2024 with Directory of 974 Partnering Deals Signed by the World's Leading Life Science Companies Since 2016 - ResearchAndMarkets.com","headline":"Monoclonal Antibody Collaboration and Licensing Deals Trends Report 2024 with Directory of 974 Partnering Deals Signed b","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQNVltbG1Ia21tLS1PM0VUNFhlUVUtVjdYSlhab3BrNm1yZTdFT01uNUk1M3ZPUmlTR2lWdFg4VU80el8yOFhnQ2NtdkE3R3FDZW9ucVRiZnYwTjR4Z05NajI0dGxjZ3UtenluaVlleWV4RmdBN2ZVOGNDMnJsUk95TWJCcDFEUGN4?oc=5","date":"2022-08-01","type":"pipeline","source":"PharmaLive","summary":"Christian Willis, PharmD, joins Peregrine Market Access - PharmaLive","headline":"Christian Willis, PharmD, joins Peregrine Market Access","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNTTFzaGxDR2RuOFp6WlBTQmVHZk80eER6dHgwdmZzeDBOUjBkMjVsQUp6RlJZOVB3M185Y3hQaWNtcVpVNVltM3BVODhHSjVPOUZrZExZMlNKWUZLOTd4UVFqVEJ5V3NsVDV4Z05LVmpJZElCVGJ3cklVWEh4c1dqd0hNb3FGMEJpd0xNM0lhTDJqU3pEM2FReG01RzF2SEE5LVUxV2h5bGh2Z1ByYk1COWFjQUI2eGtOMWNEU25FV1QzTjBWa01vNElERzE3YXI0VTk1TlVR?oc=5","date":"2019-09-07","type":"deal","source":"Saratoga.com","summary":"Peregrine Market Access, Which Deals With Pharmaceutical Issues, Opens Local Office - Saratoga.com","headline":"Peregrine Market Access, Which Deals With Pharmaceutical Issues, Opens Local Office","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxORUxyM1lXMElfSTBUMXg2SU93ckN6Sk1uRUc5bXlUMTYxWEdFVUh2SkFhVVpWbVFYV05zQlR3Y3pTQjRmMzlUbTZtZHpzQlZuZGhGdUFBWWNRNldyY2FGbkp6YlFFTUVQckFFdGZkZFVWLWJoTDQyclBKejNBQXNRcUxBMllCWGhPQXVfeGdqbmpyQ2VrYV9tZ1dWYjJ4M1k?oc=5","date":"2018-01-05","type":"pipeline","source":"Contract Pharma","summary":"Peregrine Pharmaceuticals To Become Avid Bioservices - Contract Pharma","headline":"Peregrine Pharmaceuticals To Become Avid Bioservices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxQWlEtdWlROW05R0ZhRlFFRXVXVkpPRVAwUmtaVEFRYjRsSm52cmp0ZXFHdWtMczN1UmxTM0lPUXVqdXlUTGZLZ3lYXzIzbHBvUzNHS0U1SU5nNWNSaXhmTGkyYk9QQk9UaWRIZkVlMWhwTUVqbEFETGFGSWhjVFNNR2FIMUJ2OExIak9jRUQ5cGRsSFpnb29DMkZjQkN2U21BdEdrVjJNQ3RibmR5NDRiYjVqMjBDNGM2aDdIcnpGcEtxcnZLOVFkUEUwM1JYbFJOLU9vWlJCd0otS2g4UkRweHNxMThuaXA2RC03dlhWTWI3ZVZ0b2w2SU9qVXVMWFRSMXJfTnRZWW92eTA4aFZQTTdTSlVNcVJIR25OdF93MkF0aXFGMnB0TXZ6dWVTNVhCV3JENldKdjE3UlNhdk1CTWVra2tqZWVXSENNZFVMVEV6LWh0d3c?oc=5","date":"2018-01-05","type":"pipeline","source":"GlobeNewswire","summary":"Peregrine Pharmaceuticals Announces Name Change to Avid - GlobeNewswire","headline":"Peregrine Pharmaceuticals Announces Name Change to Avid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQSWpGSnlaXzctbGtSNk1uSnhUeXJPalJfRDB6dFlUNnBGWmYycWJiVkRsRHY1eGlBa0h6N2NGdU8wLVBZd1lMRDEzLVpaYV9wWlkxMUxFVUR6YzNWSFc2Qy1iaUdHYVhhU29ETVZsTGRMNnhOaVdZRExxX2d2RUhsRmsxS0ZsUWNiSXlnVzA2Rk5fdw?oc=5","date":"2017-12-27","type":"pipeline","source":"Contract Pharma","summary":"Peregrine Pharmaceuticals Appoints New CEO - Contract Pharma","headline":"Peregrine Pharmaceuticals Appoints New CEO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":53603000,"revenuePeriod":"2019-04-30","revenueHistory":[{"value":53603000,"period":"2019-04-30"},{"value":53621000,"period":"2018-04-30"},{"value":53621000,"period":"2018-04-30"},{"value":57630000,"period":"2017-04-30"},{"value":57630000,"period":"2017-04-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":28297000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-140753000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":336557000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}